A Closer Look: With Only 60% Of China’s Sterile Drug Makers Passing New GMP Standard, What’s Next?
This article was originally published in PharmAsia News
Executive Summary
Only 60% of sterile drug manufacturers passed the new GMP standard in China, as smaller companies chose to quit the market.